640 related articles for article (PubMed ID: 30431171)
1. Assessment of combined fractional CO
Tawfic SO; Abdel Halim DM; Albarbary A; Abdelhady M
Lasers Surg Med; 2019 Jan; 51(1):27-33. PubMed ID: 30431171
[TBL] [Abstract][Full Text] [Related]
2. Tranexamic Acid Microinjection Alone Versus Its Combination With Fractional Carbon Dioxide Laser in Melasma Treatment: A Dermoscopic Evaluation.
Tawfic SO; Abdel Hay RM; Abouelazm DI; Said ER
Dermatol Surg; 2022 May; 48(5):556-561. PubMed ID: 35333207
[TBL] [Abstract][Full Text] [Related]
3. Micro-needling versus fractional carbon dioxide laser for delivery of tranexamic acid in the treatment of melasma: A split-face study.
Mekawy KMM; Sadek A; Seddeik Abdel-Hameed AK
J Cosmet Dermatol; 2021 Feb; 20(2):460-465. PubMed ID: 32562337
[TBL] [Abstract][Full Text] [Related]
4. The efficacy in treatment of facial melasma with thulium 1927-nm fractional laser-assisted topical tranexamic acid delivery: a split-face, double-blind, randomized controlled pilot study.
Wanitphakdeedecha R; Sy-Alvarado F; Patthamalai P; Techapichetvanich T; Eimpunth S; Manuskiatti W
Lasers Med Sci; 2020 Dec; 35(9):2015-2021. PubMed ID: 32506227
[TBL] [Abstract][Full Text] [Related]
5. Combining Low Power Fractional CO
Esmat S; Z Elramly A; Shahin D; Hilal RF
Lasers Surg Med; 2021 Dec; 53(10):1325-1340. PubMed ID: 34164829
[TBL] [Abstract][Full Text] [Related]
6. Clinical observation and dermoscopy evaluation of fractional CO
Qu Y; Wang F; Liu J; Xia X
J Cosmet Dermatol; 2021 Apr; 20(4):1110-1116. PubMed ID: 33565243
[TBL] [Abstract][Full Text] [Related]
7. Tranexamic acid versus fractional carbon dioxide laser in post-acne hyperpigmentation.
Tawfic SO; Abdel Hay R; Salim H; Elmasry MF
Dermatol Ther; 2021 Nov; 34(6):e15103. PubMed ID: 34414642
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of laser and topical tranexamic acid combination therapy in melasma: An updated systematic review and meta-analysis of randomized controlled trials.
Khan QA; Abdi P; Farkouh C; Anthony MR; Chundru A; Amatul F; Parimi K; Santiago N; Farkouh M; Iram S; Khan A
Lasers Med Sci; 2023 Jun; 38(1):139. PubMed ID: 37326860
[TBL] [Abstract][Full Text] [Related]
9. Low-power fractional CO₂ laser versus low-fluence Q-switch 1,064 nm Nd:YAG laser for treatment of melasma: a randomized, controlled, split-face study.
Jalaly NY; Valizadeh N; Barikbin B; Yousefi M
Am J Clin Dermatol; 2014 Aug; 15(4):357-63. PubMed ID: 24858737
[TBL] [Abstract][Full Text] [Related]
10. Tranexamic Acid for Melasma Treatment: A Split-Face Study.
Ebrahim HM; Said Abdelshafy A; Khattab F; Gharib K
Dermatol Surg; 2020 Nov; 46(11):e102-e107. PubMed ID: 32701529
[TBL] [Abstract][Full Text] [Related]
11. Intradermal injection of tranexamic acid versus platelet-rich plasma in the treatment of melasma: a split-face comparative study.
Abd Elraouf IG; Obaid ZM; Fouda I
Arch Dermatol Res; 2023 Aug; 315(6):1763-1770. PubMed ID: 36856856
[TBL] [Abstract][Full Text] [Related]
12. The efficacy of oral vs different dilutions of intradermal tranexamic acid microinjections in melasma-A randomized clinical trial.
El Hadidi H; Mosaad R; Ragab N
Dermatol Ther; 2021 May; 34(3):e14924. PubMed ID: 33651442
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic efficacy and safety of oral tranexamic acid and that of tranexamic acid local infiltration with microinjections in patients with melasma: a comparative study.
Sharma R; Mahajan VK; Mehta KS; Chauhan PS; Rawat R; Shiny TN
Clin Exp Dermatol; 2017 Oct; 42(7):728-734. PubMed ID: 28649780
[TBL] [Abstract][Full Text] [Related]
14. Split-face comparative study between intradermal tranexamic acid injection alone versus intradermal tranexamic acid injection combined with Q-switched Nd:YAG laser in melasma treatment: dermoscopic and clinical evaluation.
Hawwam SA; Ismail M; El-Attar YA
Lasers Med Sci; 2022 Jun; 37(4):2193-2201. PubMed ID: 34988730
[TBL] [Abstract][Full Text] [Related]
15. Topical 3% tranexamic acid enhances the efficacy of 1064-nm Q-switched neodymium-doped yttrium aluminum garnet laser in the treatment of melasma.
Laothaworn V; Juntongjin P
J Cosmet Laser Ther; 2018 Oct; 20(6):320-325. PubMed ID: 29461121
[No Abstract] [Full Text] [Related]
16. The treatment of melasma with topical creams alone, CO2 fractional ablative resurfacing alone, or a combination of the two: a comparative study.
Trelles MA; Velez M; Gold MH
J Drugs Dermatol; 2010 Apr; 9(4):315-22. PubMed ID: 20514787
[TBL] [Abstract][Full Text] [Related]
17. A comparative evaluation of the efficacy of intralesional tranexamic acid versus platelet rich plasma in the treatment of melasma.
Patil NK; Bubna AK
Dermatol Ther; 2022 Jul; 35(7):e15534. PubMed ID: 35460158
[TBL] [Abstract][Full Text] [Related]
18. Tranexamic acid microinjections versus tranexamic acid mesoneedling in the treatment of facial melasma: A randomized assessor-blind split-face controlled trial.
Poostiyan N; Alizadeh M; Shahmoradi Z; Fatemi Naeini F
J Cosmet Dermatol; 2023 Apr; 22(4):1238-1244. PubMed ID: 36606390
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and Safety of Topical Tranexamic Acid Alone or in Combination with Either Fractional Carbon Dioxide Laser or Microneedling for the Treatment of Melasma.
Mamdouh Kamal Dawaud S; Hegab DS; Mohamed El Maghraby G; Ahmad El-Ashmawy A
Dermatol Pract Concept; 2023 Jul; 13(3):. PubMed ID: 37557109
[TBL] [Abstract][Full Text] [Related]
20. Study of oral tranexamic acid, topical tranexamic acid, and modified Kligman's regimen in treatment of melasma.
Sahu PJ; Singh AL; Kulkarni S; Madke B; Saoji V; Jawade S
J Cosmet Dermatol; 2020 Jun; 19(6):1456-1462. PubMed ID: 32346962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]